706 related articles for article (PubMed ID: 19301261)
21. Inhibition of interleukin-4 production in activated T cells via the downregulation of AP-1/NF-AT activation by N-lauroyl-D-erythro-sphingosine and N-lauroyl-D-erythro-C20-sphingosine.
Park J; Kim SH; Li Q; Chang YT; Kim TS
Biochem Pharmacol; 2006 Apr; 71(8):1229-39. PubMed ID: 16448625
[TBL] [Abstract][Full Text] [Related]
22. New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.
Mortellaro A; Songia S; Gnocchi P; Ferrari M; Fornasiero C; D'Alessio R; Isetta A; Colotta F; Golay J
J Immunol; 1999 Jun; 162(12):7102-9. PubMed ID: 10358154
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of AMP-activated protein kinase suppresses IL-2 expression through down-regulation of NF-AT and AP-1 activation in Jurkat T cells.
Jhun BS; Lee JY; Oh YT; Lee JH; Choe W; Baik HH; Kim SS; Yoon KS; Ha J; Kang I
Biochem Biophys Res Commun; 2006 Dec; 351(4):986-92. PubMed ID: 17097050
[TBL] [Abstract][Full Text] [Related]
24. IL-2-independent activation and proliferation in human T cells induced by CD28.
Boulougouris G; McLeod JD; Patel YI; Ellwood CN; Walker LS; Sansom DM
J Immunol; 1999 Aug; 163(4):1809-16. PubMed ID: 10438913
[TBL] [Abstract][Full Text] [Related]
25. Effects of esculentoside A on autoimmune syndrome induced by Campylobacterjejuni in mice and its modulation on T-lymphocyte proliferation and apoptosis.
Hu Z; Qiu L; Xiao Z; Wang J; Yu Q; Li J; Feng H; Guo C; Zhang J
Int Immunopharmacol; 2010 Jan; 10(1):65-71. PubMed ID: 19818416
[TBL] [Abstract][Full Text] [Related]
26. Regulation of interferon-gamma, interleukin-4 and interleukin-2 by Schizonepeta tenuifolia through differential effects on nuclear factor-kappaB, NFATc2 and STAT4/6.
Kang H; Moon JY; Sohn NW
Exp Biol Med (Maywood); 2010 Feb; 235(2):230-6. PubMed ID: 20404039
[TBL] [Abstract][Full Text] [Related]
27. (5R)-5-hydroxytriptolide inhibits IFN-gamma-related signaling.
Zhou R; Wang JX; Tang W; He PL; Yang YF; Li YC; Li XY; Zuo JP
Acta Pharmacol Sin; 2006 Dec; 27(12):1616-21. PubMed ID: 17112417
[TBL] [Abstract][Full Text] [Related]
28. Pseudoephedrine inhibits T-cell activation by targeting NF-κB, NFAT and AP-1 signaling pathways.
Fiebich BL; Collado JA; Stratz C; Valina C; Hochholzer W; Muñoz E; Bellido LM
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):98-106. PubMed ID: 21631396
[TBL] [Abstract][Full Text] [Related]
29. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro.
Haddad JJ
Mol Immunol; 2009 Dec; 47(2-3):205-14. PubMed ID: 19850345
[TBL] [Abstract][Full Text] [Related]
30. Increased IL-2 production in T cells by xanthohumol through enhanced NF-AT and AP-1 activity.
Choi JM; Kim HJ; Lee KY; Choi HJ; Lee IS; Kang BY
Int Immunopharmacol; 2009 Jan; 9(1):103-7. PubMed ID: 19019318
[TBL] [Abstract][Full Text] [Related]
31. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M
Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541
[TBL] [Abstract][Full Text] [Related]
32. Alpha 4 beta 1 (CD49d/CD29) integrin costimulation of human T cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti-CD3 stimulation.
Udagawa T; Woodside DG; McIntyre BW
J Immunol; 1996 Sep; 157(5):1965-72. PubMed ID: 8757316
[TBL] [Abstract][Full Text] [Related]
33. The effects of saikosaponin on macrophage functions and lymphocyte proliferation.
Ushio Y; Abe H
Planta Med; 1991 Dec; 57(6):511-4. PubMed ID: 1818339
[TBL] [Abstract][Full Text] [Related]
34. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
[TBL] [Abstract][Full Text] [Related]
35. NF-kappaB-regulated suppression of T-bet in T cells represses Th1 immune responses in pregnancy.
McCracken SA; Hadfield K; Rahimi Z; Gallery ED; Morris JM
Eur J Immunol; 2007 May; 37(5):1386-96. PubMed ID: 17407192
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of interleukin-4 production via NF-AT/AP-1 activation in T cells by biochanin A, a phytoestrogen and its metabolites.
Park J; Chung SW; Kim SH; Kim TS
Toxicol Appl Pharmacol; 2006 May; 212(3):188-99. PubMed ID: 16169028
[TBL] [Abstract][Full Text] [Related]
37. Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways.
Ma X; Dang C; Kang H; Dai Z; Lin S; Guan H; Liu X; Wang X; Hui W
Int Immunopharmacol; 2015 Sep; 28(1):399-408. PubMed ID: 26118633
[TBL] [Abstract][Full Text] [Related]
38. The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway.
Vega Lde L; Muñoz E; Calzado MA; Lieb K; Candelario-Jalil E; Gschaidmeir H; Färber L; Mueller W; Stratz T; Fiebich BL
Biochem Pharmacol; 2005 Aug; 70(3):369-80. PubMed ID: 15922994
[TBL] [Abstract][Full Text] [Related]
39. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.
Park J; Ahn KS; Bae EK; Kim BS; Kim BK; Lee YY; Yoon SS
Anticancer Drugs; 2008 Sep; 19(8):777-82. PubMed ID: 18690088
[TBL] [Abstract][Full Text] [Related]
40. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways.
Lin YL; Liang YC; Tseng YS; Huang HY; Chou SY; Hseu RS; Huang CT; Chiang BL
J Leukoc Biol; 2009 Oct; 86(4):877-89. PubMed ID: 19498044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
